跳至主要内容
临床试验/EUCTR2011-003190-29-DE
EUCTR2011-003190-29-DE进行中(未招募)不适用

Optimizing Antidepressant Treatment by Genotype-dependent Adjustment of Medication according to the the ABCB1 Gene - ABCB1 Clinical Study

HolsboerMaschmeyer NeuroChemie (HMNC) GmbH0 个研究点开始时间: 2011年8月16日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • - Male and female patients
  • - Age between 18 and 80 years
  • - In-patients with a DSM-IV diagnosis of Major Depression
  • - - single episode or recurrent
  • - - moderate or severe intensity (indicated by a HAM-D score of = 14)
  • - - without psychotic features
  • - In-patients with a DSM-IV diagnosis of Bipolar Disorder
  • - - current episode depressed
  • - - moderate or severe intensity (indicated by a HAM-D score of = 14)
  • - - without psychotic features
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 100
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 20

排除标准

  • - Acute suicidality (indicated by a HAM-D Item 3 score > 2)
  • - Acute substance abuse
  • - Severe somatic or neurological disorders
  • - Acute functional kidney disorders
  • - Untreated hypertonia
  • - In female patients: current pregnancy or breast feeding

研究者

发起方
HolsboerMaschmeyer NeuroChemie (HMNC) GmbH

相似试验

Adjusting antidepressant dosage according to the... | 临床试验